CD274 and neoplasm: Some kinase inhibitors23, particularly cyclin-dependent kinase 5 inhibitors24, and some natural compounds as baicalin25 are shown to attenuate tumour PD-L1 expression, but their therapeutic efficacies are generally low even in animal models26,27.